Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-flow Nasal Cannula Nebulization of Beta 2 Adrenergic Agonist During Acute Exacerbation of Chronic Obstructive Pulmonary Disease

NCT03449056 is registered in ClinicalTrials.gov with Poitiers University Hospital as lead sponsor.

NCT NCT03449056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03449056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-flow Nasal Cannula Nebulization of Beta 2 Adrenergic Agonist During Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Lead sponsor
Poitiers University Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
January 11, 2019
Completion date
April 30, 2020
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease, high-flow nasal cannula